$40.10
1.45[3.75%]
At close: Apr 19
$40.10
0[0.00%]
After Hours: 4:03PM EDT
Amphastar Pharma
(NASDAQ:AMPH)Latest News for Amphastar Pharma Stock (NASDAQ:AMPH)
Amphastar Pharma Stock (NASDAQ: AMPH)
Categories: All
Wednesday, April 10, 2024
Tuesday, March 05, 2024
Thursday, February 29, 2024
Wednesday, February 28, 2024
- Amphastar Pharmaceuticals shares are trading lower after the company reported mixed Q4 financial results.Benzinga Newsdesk - Feb 28, 2024, 4:45PM
- Amphastar Pharma Q4 EPS $0.88 Misses $0.91 Estimate, Sales $178.10M Beat $175.67M EstimateHappy Mohamed - Feb 28, 2024, 4:25PM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
Tuesday, February 27, 2024
Friday, January 19, 2024
Wednesday, January 17, 2024
Tuesday, November 21, 2023
Friday, November 17, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
Wednesday, September 13, 2023
Tuesday, September 12, 2023
Monday, September 11, 2023
Tuesday, August 22, 2023
Thursday, August 17, 2023
Tuesday, August 08, 2023
Tuesday, July 25, 2023
Thursday, June 22, 2023
Thursday, June 15, 2023
Wednesday, May 17, 2023
- Amphastar Pharma Director Trades Company's StockBenzinga Insights - May 17, 2023, 11:05AM
- Amphastar Pharma Board Member Acquires 10,000 Shares After Exercising Company Stock OptionsBenzinga Insights - May 17, 2023, 11:01AM
- Wells Fargo Maintains Equal-Weight on Amphastar Pharma, Raises Price Target to $44Benzinga Newsdesk - May 17, 2023, 9:13AM
Tuesday, May 09, 2023
Monday, May 08, 2023
Monday, April 24, 2023
- Elon Musk Plans Next Starship Launch Within Two Months, NBCUniversal CEO Resigns Amid 'Inappropriate Relationship, Micron Tech Caught Between US-China Tensions: Today's Top StoriesVandana Singh - Apr 24, 2023, 10:34AM
- Amphastar Pharmaceuticals shares are trading lower after Eli Lilly announced the divestment of BAQSIMI to the company for a cash payment of $500 million at closing and an additional $125 million in cash upon the one-year anniversary of closing.Michael Horton - Apr 24, 2023, 10:21AM
- Eli Lilly Divests Low Blood Sugar Drug Baqsimi To Amphastar For $500M CashVandana Singh - Apr 24, 2023, 8:25AM
- Eli Lilly Will Divest Baqsimi Worldwide To Amphastar For $500M At Closing And An Additional $125M After One Year. Baqsimi Is Nasally Administered Glucagon For Severe Hypoglycemia (Low Blood Sugar Levels) In People With Diabetes.Benzinga Newsdesk - Apr 24, 2023, 6:50AM